TG Therapeutics, Inc. to Present at Upcoming Investment Conferences
Mar 07, 2016 12:30 pm UTC| Business
NEW YORK, March 07, 2016 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced its participation at two upcoming investment conferences. Michael S. Weiss, the Company’s Executive Chairman and Interim Chief Executive...
Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for Biovance®
Mar 07, 2016 12:30 pm UTC| Business
YARDLEY, Pa., March 07, 2016 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced that Biovance® Human Amniotic Membrane Allograft is now...
Marinus Pharmaceuticals Provides Business Update and 2015 Financial Results
Mar 07, 2016 12:30 pm UTC| Business
RADNOR, Pa., March 07, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...
Mar 07, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 07, 2016 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Aehr Test Systems to Exhibit at Burn-in and Test Strategies Workshop in Mesa, AZ March 6-9
Mar 07, 2016 12:30 pm UTC| Business
FREMONT, Calif., March 07, 2016 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will exhibit in Booth A28 at the 17th annual Burn-in and Test...
Spark Therapeutics Announces Acquisition of Genable Technologies
Mar 07, 2016 12:20 pm UTC| Business
PHILADELPHIA, March 07, 2016 -- Spark Therapeutics (NASDAQ:ONCE) today announced that it has acquired Dublin, Ireland-based Genable Technologies, a private gene therapy innovator with which Spark has collaborated since...
Galena Biopharma to Present at the 28th Annual ROTH Conference
Mar 07, 2016 12:05 pm UTC| Business
SAN RAMON, Calif., March 07, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet...